SAN FRANCISCO — Artificial intelligence developer Anthropic raised $81.3 billion in the largest initial public offering in history, the company announced late Wednesday, topping the record set earlier this year by SpaceX.
The San Francisco-based firm behind the Claude chatbot sold 980 million shares at $83 per share, according to company statements reported by Al Jazeera English. The pricing exceeded Anthropic’s expected range of $70 to $78 per share and increased the number of offered shares from an initial target of 825 million after investor demand was reported to be six times higher than the available supply. The stock is scheduled to begin public trading Thursday on the Nasdaq stock exchange under the ticker symbol “ANT.”
A Record-Breaking Valuation
At $83 per share, the offering gives Anthropic a market capitalization of approximately $1.5 trillion. That valuation positions Anthropic as the world’s 12th-largest publicly traded company, sitting just behind electric vehicle maker Tesla, Al Jazeera English reported.
In addition to the public share sale, Anthropic is set to secure $26 billion through a private placement of stock, bringing its total capital raised in the deal to $107.3 billion. The $81.3 billion raised in the IPO surpasses the initial $75 billion raised by Elon Musk’s SpaceX in June 2026, though SpaceX’s ultimate total reached $85.7 billion after underwriters exercised options to purchase additional shares.
Anthropic was established in 2021 by seven former employees of rival AI company OpenAI, including brother and sister Dario and Daniela Amodei. The company operates primarily by selling commercial access to its Claude suite of AI models. It previously raised $124 million from initial investors five years ago and secured $65 billion from private backers at a $965 billion valuation in May 2026 before confidentially filing for an IPO in June.
Rapid Growth Alongside Heavy Expenses
Anthropic’s public filings reveal both rapid revenue expansion and massive spending commitments. Company documentation made public in late October showed revenue of $33.2 billion over the first nine months of 2026, which included $17 billion generated in the third quarter alone, according to reports by Al Jazeera English.
However, the November prospectus also disclosed a net loss of $104 billion for the nine-month period, which the company noted was primarily caused by non-cash accounting adjustments. Anthropic also detailed nearly $901 billion in long-term commitments for computing and infrastructure needed to train and run its technology models.
The historic public offering comes during a period of volatility across the technology sector. The tech-heavy Nasdaq Composite index has dropped 7.6 percent over the past month, influenced by a decline of more than 30 percent in Nvidia’s share price following the recent resignation of chief executive Jensen Huang, Al Jazeera English reported.
Market Impact and What Comes Next
Despite broader market headwinds, analysts described Anthropic’s debut as a sign of continued appetite for artificial intelligence ventures. Technology insights firm Gartner projects global AI spending to reach $2.7 trillion in 2026 and $3.6 trillion in 2027.
Dan Ives, a partner and senior managing director at Yorkville Ives, noted in a client release that the debut offers a boost to investor sentiment during a turbulent stretch for tech equities. Ives projected that between $3 trillion and $4 trillion will be spent on capital expenditures for AI infrastructure over the coming years, with Anthropic expected to play a central role.
“Anthropic’s IPO is a big near-term win for the tech sector and should help restore some investor confidence that the AI revolution growth thesis is not waning,” Ives wrote.
Jay R. Ritter, an IPO specialist at the University of Florida, told Al Jazeera English that Anthropic’s long-term profitability will rely on factors both inside and outside its direct control. Ritter drew parallels to early internet debuts, noting strong investor interest in the potential of AI models to assist with medical breakthroughs, such as identifying treatments for cancer and dementia.
Attention now turns to how the stock performs when Wall Street opens Thursday morning, as well as whether underwriters will exercise overallotment options that could further boost the total funds raised.



